RESP (Respiratory ECMO Survival Prediction) Score

The RESP score predicts hospital survival at the time of ECMO initiation for severe acute respiratory failure using pre‑ECMO clinical variables 1.

Age, years
≥ 60-350-59-218-490
Immunocompromised status at time of ECMO
Yes-2No0
Mechanically ventilated before ECMO initiated
> 7 days048 hrs to 7 days+1< 48 hrs+3
Diagnosis
Nonrespiratory or chronic respiratory diagnosis0Other acute respiratory diagnosis+1Viral pneumonia+3Bacterial pneumonia+3Trauma or burn+3Aspiration pneumonitis+5Asthma+11
History of CNS dysfunction
Yes-7No0
Acute associated nonpulmonary infection
Yes-3No0
Neuromuscular blockade before ECMO
No0Yes+1
Nitric oxide before ECMO
Yes-1No0
Bicarbonate infusion before ECMO
Yes-2No0
Cardiac arrest before ECMO
Yes-2No0
PaCO2 ≥ 75 mmHg (≥ 10 kPa)
Yes-1No0
Peak inspiratory pressure ≥ 42 cm H2O (≥ 4.1 kPa)
Yes-1No0

Indications for Use

Used for adults with severe acute respiratory failure being evaluated for or starting VV‑ECMO, to estimate hospital‑survival probability using pre‑ECMO variables. Supports risk stratification, resource allocation, and comparisons of center outcomes. Derived in 2,355 ECMO patients with c‑statistic 0.74 and externally validated (c 0.92) 1 [Level I evidence].

Insights & Cautions

Improves survival prediction modestly at ECMO initiation with c≈0.74 in derivation (2,355 patients, ELSO registry) 1. Limitations: not validated for patient selection, only for risk adjustment; performs poorly in COVID-19 (AUC 0.61) 2; and external performance varies. Use cautiously—heterogeneous ARDS etiologies and center‑level variation can reduce reliability 3.